Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Disposition of ketoconazole, an oral antifungal, in humans.

Brass C, Galgiani JN, Blaschke TF, Defelice R, O'Reilly RA, Stevens DA.

Antimicrob Agents Chemother. 1982 Jan;21(1):151-8.

2.

Clinical pharmacokinetics of systemic antifungal drugs.

Daneshmend TK, Warnock DW.

Clin Pharmacokinet. 1983 Jan-Feb;8(1):17-42. Review. No abstract available.

PMID:
6301738
3.

Pharmacokinetics of ketoconazole in patients with neoplastic diseases.

Maksymiuk AW, Levine HB, Bodey GP.

Antimicrob Agents Chemother. 1982 Jul;22(1):43-6.

4.

Impairing effect of food on ketoconazole absorption.

Männistö PT, Mäntylä R, Nykänen S, Lamminsivu U, Ottoila P.

Antimicrob Agents Chemother. 1982 May;21(5):730-3.

5.

Distribution of oral ketoconazole to vaginal tissue.

Heykants JJ, Woestenborghs RJ, Bisschop MP, Merkus JM.

Eur J Clin Pharmacol. 1982 Oct;23(4):331-3.

PMID:
6293835
6.

Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.

Perucca E, Cloyd J, Critchley D, Fuseau E.

Epilepsia. 2008 Jul;49(7):1123-41. doi: 10.1111/j.1528-1167.2008.01665.x.

7.

Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.

Persiani S, D'Amato M, Makovec F, Tavares IA, Bishai PM, Rovati LC.

Int J Clin Pharmacol Ther. 2002 May;40(5):198-206.

PMID:
12051571
8.

Evaluation of ketoconazole.

Sohn CA.

Clin Pharm. 1982 May-Jun;1(3):217-24. Review.

PMID:
6309466
9.

High-dose ketoconazole for treatment of fungal infections of the central nervous system.

Craven PC, Graybill JR, Jorgensen JH, Dismukes WE, Levine BE.

Ann Intern Med. 1983 Feb;98(2):160-7.

PMID:
6297345
10.

Effect of ketoconazole on hepatic oxidative drug metabolism.

Brown MW, Maldonado AL, Meredith CG, Speeg KV Jr.

Clin Pharmacol Ther. 1985 Mar;37(3):290-7.

PMID:
3971653
11.

Ketoconazole.

Hume AL, Kerkering TM.

Drug Intell Clin Pharm. 1983 Mar;17(3):169-74. Review.

PMID:
6301794
12.

The pharmacokinetics of ketoconazole in severely immunocompromised patients.

Hann IM, Prentice HG, Keaney M, Corringham R, Blacklock HA, Fox J, Gascoigne E, Van Cutsem J.

J Antimicrob Chemother. 1982 Dec;10(6):489-96. No abstract available.

PMID:
6298171
13.
14.
15.

Pharmacokinetics of cyclosporine in heart transplant recipients receiving metabolic inhibitors.

Akhlaghi F, Keogh AM, McLachlan AJ, Kaan A.

J Heart Lung Transplant. 2001 Apr;20(4):431-8.

PMID:
11295581
16.

Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine.

McEnroe JD, Fleishaker JC.

Clin Pharmacokinet. 2005;44(3):237-46. Review.

PMID:
15762767
17.

Ketoconazole.

Daneshmend TK, Roberts CJ.

Lancet. 1982 Feb 27;1(8270):517. No abstract available.

PMID:
6121176
18.

Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastine.

Pesco-Koplowitz L, Hassell A, Lee P, Zhou H, Hall N, Wiesinger B, Mechlinski W, Grover M, Hunt T, Smith R, Travers S.

J Clin Pharmacol. 1999 Jan;39(1):76-85.

PMID:
9987703
19.

Blood concentrations of everolimus are markedly increased by ketoconazole.

Kovarik JM, Beyer D, Bizot MN, Jiang Q, Shenouda M, Schmouder RL.

J Clin Pharmacol. 2005 May;45(5):514-8.

PMID:
15831774
20.

Supplemental Content

Support Center